Avricore Health Inc. AVCR.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -93.69% | -96.47% | -89.27% | -60.64% | -32.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -93.69% | -96.47% | -89.27% | -60.64% | -32.98% |
| Cost of Revenue | -85.15% | -88.93% | -90.02% | -63.94% | -39.90% |
| Gross Profit | -105.13% | -106.75% | -88.10% | -55.26% | -20.74% |
| SG&A Expenses | -41.91% | -29.05% | -15.48% | -1.72% | 18.93% |
| Depreciation & Amortization | 3.57% | 48.00% | -36.36% | 73.68% | 47.37% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -62.62% | -62.96% | -62.52% | -41.73% | -19.09% |
| Operating Income | -98.87% | -1,985.12% | -775.48% | -559.87% | -1,157.07% |
| Income Before Tax | -26.73% | -118.89% | -181.13% | -1,619.61% | -24,328.57% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.73% | -118.89% | -181.13% | -1,619.61% | -24,328.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.73% | -118.89% | -181.13% | -1,619.61% | -24,328.57% |
| EBIT | -98.87% | -1,985.12% | -775.48% | -559.87% | -1,157.07% |
| EBITDA | -273.73% | -518.87% | -271.03% | -190.14% | -154.49% |
| EPS Basic | -26.73% | -121.88% | -186.96% | -1,537.50% | -- |
| Normalized Basic EPS | -96.30% | -1,120.00% | -1,200.00% | -1,000.00% | -2,600.00% |
| EPS Diluted | -26.73% | -121.88% | -186.96% | -2,975.00% | -2,425.00% |
| Normalized Diluted EPS | -96.30% | -1,120.00% | -1,200.00% | -1,000.00% | -2,600.00% |
| Average Basic Shares Outstanding | 1.12% | 0.59% | 0.97% | 1.36% | 1.33% |
| Average Diluted Shares Outstanding | 1.12% | -0.83% | -0.45% | -0.07% | -0.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |